EUVIMEDEUVIMED entdecken
Crossref

Similar Tolerance of Glucagon‐Like PEPTIDE‐1 Agonist Therapy in Patients With Delayed and Normal Gastric Emptying

Stacey C Rolak iD, Tisha N Lunsford iD, Rosita D Frazier, Lucinda A Harris iD, Ming Yang iD, William L Hasler iD

Neurogastroenterology & Motility · 2026-11 · 38 (11)

DOI: 10.1111/nmo.70448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 05.11.2026. Verfasst von Stacey C Rolak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Scottsdale, Arizona, USA. Hauptthemen laut MEDLINE: Gastric Emptying, Gastroparesis, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gastroparesis is considered a relative contraindication to glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) prescription. We examined outcomes of patients who underwent gastric scintigraphy to determine if emptying delays adversely affected tolerance of subsequent GLP‐1RA therapy.

Methods

Patients with delayed (DGE) and normal (NGE) gastric emptying who were subsequently prescribed GLP‐1RAs were identified. GLP‐1RA prescribing profiles, gastrointestinal (GI) symptoms and treatments, and GLP‐1RA discontinuation were compared between patients with DGE versus NGE. Key Results Eighty‐one patients were prescribed GLP‐1RAs after scintigraphy; 14/81 (17%) with DGE and 67/81 (83%) with NGE. Injectable semaglutide was most often prescribed and was taken at similar doses for DGE (11/14, 79%) and NGE (40/67, 60%) ( p = 0.23). GLP‐1RAs were initiated a median of 386 days (IQR 190, 474) after scintigraphy with DGE versus 315 days (IQR 157, 613) with NGE ( p = 0.86). GI symptoms developed in 5/14 (36%) with DGE versus 35/67 (52%) with NGE ( p = 0.38) and antiemetic ( p = 0.75) and prokinetic ( p = 1.00) use was similar between groups. GLP‐1RAs were discontinued in 45/81 (56%) patients including 14/45 (31%) for GI symptoms, which occurred similarly for DGE (3/8, 38%) and NGE (11/37, 30%) ( p = 0.70). Treatment durations were similar with DGE (318 days [IQR 223, 464]) versus NGE (193 days [IQR 83, 363]) ( p = 0.31). Conclusions and Inferences GLP‐1RAs are taken at similar doses for similar durations, elicit similar symptoms, and are discontinued for similar reasons in patients with prior delayed versus normal gastric emptying. These observations do not support strictly avoiding GlP‐1RAs in gastroparesis and suggest they may be safely prescribed in many cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric EmptyingGastroparesisGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsDrug ToleranceHumansFemaleMaleMiddle AgedSemaglutideRadionuclide ImagingGlucagon-Like PeptidesAdultAgedRetrospective Studies

Stichwörter der Autor:innen

antiemetic medicationsgastric emptying scintigraphygastroparesisobesityprokinetic medicationstype 2 diabetes mellitus

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsSemaglutideGlucagon-Like PeptidesHypoglycemic Agents

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
  • Division of Nuclear Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.

ORCID-Profile: Stacey C Rolak, Tisha N Lunsford, Lucinda A Harris, Ming Yang, William L Hasler

Zitieren

APA

Rolak, S. C., Lunsford, T. N., Frazier, R. D., Harris, L. A., Yang, M., & Hasler, W. L. (2026). Similar Tolerance of Glucagon‐Like PEPTIDE‐1 Agonist Therapy in Patients With Delayed and Normal Gastric Emptying. Neurogastroenterology & Motility, 38(11). https://doi.org/10.1111/nmo.70448

Vancouver

Rolak SC, Lunsford TN, Frazier RD, Harris LA, Yang M, Hasler WL. Similar Tolerance of Glucagon‐Like PEPTIDE‐1 Agonist Therapy in Patients With Delayed and Normal Gastric Emptying. Neurogastroenterology & Motility. 2026;38(11). doi:10.1111/nmo.70448

BibTeX
@article{Rolak2026,
  author = {Rolak, Stacey C and Lunsford, Tisha N and Frazier, Rosita D and Harris, Lucinda A and Yang, Ming and Hasler, William L},
  title = {Similar Tolerance of Glucagon‐Like PEPTIDE‐1 Agonist Therapy in Patients With Delayed and Normal Gastric Emptying},
  journal = {Neurogastroenterology & Motility},
  year = {2026},
  volume = {38},
  number = {11},
  doi = {10.1111/nmo.70448}
}
Kostenlos starten →